Legal & General Group’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.75M | Buy |
102,646
+8,023
| +8% | +$136K | ﹤0.01% | 2016 |
|
|
2025
Q1 | $1.85M | Buy |
94,623
+21,281
| +29% | +$416K | ﹤0.01% | 1955 |
|
|
2024
Q4 | $1.82M | Buy |
73,342
+1,586
| +2% | +$39.3K | ﹤0.01% | 2009 |
|
|
2024
Q3 | $1.76M | Buy |
71,756
+1,117
| +2% | +$27.4K | ﹤0.01% | 2035 |
|
|
2024
Q2 | $1.66M | Sell |
70,639
-2,919
| -4% | -$68.4K | ﹤0.01% | 2025 |
|
|
2024
Q1 | $2.43M | Buy |
73,558
+3,010
| +4% | +$99.5K | ﹤0.01% | 1849 |
|
|
2023
Q4 | $1.92M | Buy |
70,548
+822
| +1% | +$22.4K | ﹤0.01% | 1977 |
|
|
2023
Q3 | $1.68M | Buy |
69,726
+14,463
| +26% | +$348K | ﹤0.01% | 1976 |
|
|
2023
Q2 | $1.76M | Sell |
55,263
-891
| -2% | -$28.5K | ﹤0.01% | 1982 |
|
|
2023
Q1 | $1.72M | Buy |
56,154
+2,929
| +6% | +$89.7K | ﹤0.01% | 1945 |
|
|
2022
Q4 | $2.08M | Sell |
53,225
-659
| -1% | -$25.8K | ﹤0.01% | 1868 |
|
|
2022
Q3 | $2.57M | Sell |
53,884
-2,640
| -5% | -$126K | ﹤0.01% | 1730 |
|
|
2022
Q2 | $2.19M | Buy |
56,524
+13,863
| +32% | +$537K | ﹤0.01% | 1847 |
|
|
2022
Q1 | $2.45M | Buy |
42,661
+4,275
| +11% | +$245K | ﹤0.01% | 1898 |
|
|
2021
Q4 | $3.06M | Buy |
38,386
+1,179
| +3% | +$94K | ﹤0.01% | 1835 |
|
|
2021
Q3 | $3.24M | Buy |
37,207
+7,904
| +27% | +$688K | ﹤0.01% | 1766 |
|
|
2021
Q2 | $3.77M | Buy |
29,303
+4,108
| +16% | +$529K | ﹤0.01% | 1685 |
|
|
2021
Q1 | $2.02M | Buy |
25,195
+16,994
| +207% | +$1.36M | ﹤0.01% | 1979 |
|
|
2020
Q4 | $669K | Buy |
8,201
+3,210
| +64% | +$262K | ﹤0.01% | 2198 |
|
|
2020
Q3 | $123K | Buy |
4,991
+2,260
| +83% | +$55.7K | ﹤0.01% | 2436 |
|
|
2020
Q2 | $77K | Buy |
2,731
+824
| +43% | +$23.2K | ﹤0.01% | 2599 |
|
|
2020
Q1 | $34K | Buy |
+1,907
| New | +$34K | ﹤0.01% | 2718 |
|